Should we avoid transfusion in the pediatric intensive care unit?

Pediatric Critical Care Medicine

Volumn 10, Issue 3, 2009, Pages 400-401

  Gauvin, France ^a   Lacroix, Jacques ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acute lung injury; Blood; Critical care; Erythrocyte; Intensive care; Mortality; Plasma; Platelets; Transfusion reaction

Indexed keywords

PLASMA SUBSTITUTE;

ACUTE LUNG INJURY; BLEEDING; CLINICAL RESEARCH; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; EDITORIAL; ERYTHROCYTE TRANSFUSION; HUMAN; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK FACTOR; SEPTIC SHOCK; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; BLOOD TRANSFUSION; CHILD; NOTE; RISK ASSESSMENT; UTILIZATION REVIEW;

BLOOD TRANSFUSION; CHILD; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; RISK ASSESSMENT;

EID: 68849085926     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31819adef8     Document Type: Editorial

References (11)

1. Mettauer N, Brierley J: A novel use of etomi-date for intentional adrenal suppression to control severe hypercortisolemia in childhood. Pediatr Crit Care Med 2009; 10: e34-e37
2. Greening JE, Brain CE, Perry LA, et al: Efficient short-term control of hypercortisolae-mia by low dose etomidate in severe paedi-atric Cushing's disease. Horm Res 2005; 64: 140-143
3. den Brinker M, Hokken-Koelega ACS, Hazelzet JA, et al: One single dose of etomidate negatively influences adrenocortical performance for at least 24 h in children with meningo-coccal sepsis. Intensive Care Med 2008; 34: 163-168
4. Vinclair M, Broux C, Faure P, et al: Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008; 34:714-719
5. Malerba G, Romano-Girard F, Cravoisy A, et al: Risk factors of relative adrenocortical de-ficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 2005; 31:388-392
6. Cotton BA, Guillamondegui OD, Fleming SB, et al: Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg 2008; 143:62-67
7. Zed PJ, Mabasa VH, Slavik RS, et al: Etomidate for rapid sequence intubation in the emergency department: Is adrenal suppression a concern? Can J Emerg Med 2006; 8:347-350
8. Jackson WL: Should we use etomidate as an induction agent in patients with septic shock?: A critical appraisal. Chest 2005; 127:1031-1038
9. Murray H, Marik PE: Etomidate for endotra-cheal intubation in sepsis: Acknowledging the good while accepting the bad. Chest 2005; 127:707-709
10. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
11. Sprung CL, Annane D, Keh D, et al; CORTI-CUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124